• Abel Archundia is the Head of IT Business Partner Pharmaceuticals, at Bayer Pharmaceuticals.
• Abel joined Bayer in 2017 and is also a member of the Bayer Group IT board.
• He is responsible for driving Bayer Pharmaceutical's digital transformation.
• He is driven by the power of technology, leveraging data science to improve patient health outcomes.
• He was previously Global CIO of Sandoz (a Novartis division) and Global Head of TechOps/QA IT at Novartis.

 What is the pop in your job? What drives you? What is your passion? "I am incredibly passionate about the potential of technology and data science to radically, and sustainably, improve and transform patient health. This is what gets me up and feeling enthusiastic about working at Bayer every day. The future is certainly exciting for this industry!"

 

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our products and services are designed to benefit people and improve their quality of life. At the same time, we aim to create value through innovation, growth and high earning power. Our products help address some of today’s biggest challenges, including global population growth, an aging society and the need to make efficient – and, wherever possible, sustainable – use of natural resources. In line with our mission “Bayer: Science For A Better Life,” we aim to improve people’s quality of life by preventing, alleviating or curing diseases. We also help provide an adequate supply of high-quality food, feed and renewable plant-based raw materials. For these endeavors, we focus on developing and successfully commercializing innovative products and solutions based on scientific knowledge.